Efficacy of Enrofloxacin in the Treatment of Recurrent Pyoderma in Dogs by Reddy, B. Sudhakara et al.
Introduction
Staphylococcal pyoderma is a common skin disor-
der of the dogs. Infections may be superficial, deep,
or both. Staphylococcus intermedius is the most
commonly isolated bacterium. Systemic antibiotic
therapy is usually required; commonly recom-
mended antibiotics include B-lactamase-resistant
compounds, such as clindamycin, lincomycin, po-
tentiated sulfonamides, amoxicillin clavulanate,
cephalosporins, and fluoroquinolones. Most of the
staphylococci bacteria cultured from the recurrent
pyodermas are susceptible, in-vitro, to fluoro-
quinolones (Scott et al., 2001; Reddy et al., 2011).
Recurrent pyoderma is an important clinical skin
problem in dogs and frequently occurs as a result
of uncorrected under lying cause(s) or use of inap-
propriate antibiotics or improper duration of antibi-
otic therapy (Ihrke, 2005). Fluoroquinolones are
broad-spectrum bactericidal antibiotics with a high
bioavailability. Though use of enrofloxacin is not
unusual in the treatment of first time pyoderma, no
in-depth study reports are available regarding its
efficacy in cases of recurrent pyoderma in dogs. Ef-
fect of enrofloxacin in canine staphylococcal pyo-
derma was recorded in two decades back in abroad
(Paradis et al., 1990). But, details regarding the use
of enrofloxacin in the treatment of recurrent pyo-
derma in dogs were lacking in India. This paper re-
ports the efficacy of enrofloxacin in the treatment
of recurrent pyoderma in dogs and simultaneous
treatment of associate conditions responsible for
recurrent pyoderma.
Materials and methods
The present investigation was carried out on the
dogs referred to the College Hospital of College of
Veterinary Science, Tirupati and presented at major
Veterinary Hospitals around Tirupati. Dogs with a
history of more than three episodes of skin infec-
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Dogs with a history of more than three episodes of skin infections in a period of one year were selected for a study on
recurrent pyoderma. Oral enrofloxacin along with appropriate simultaneous medication for the underlying associated condi-
tions were chosen as therapy for recurrent pyoderma in dogs. Response to therapy was excellent in all the cases. Improvement
was noticed by 12 to 20 days and 20 to 26 days in recurrent superficial and deep pyoderma respectively. Relapse occurred
in one dog by 45 days due to re-introduction of allergic food. Enrofloxacin proved to be an effective, safe and convenient
antibiotic for the treatment of recurrent pyoderma in dogs. 
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tions in the past one year were included in the study
as also done by Bensignor and Germain (2004).
Thorough clinical examination was carried out to
identify external parasitic infestation, to note the
nature and distribution of lesions besides obtaining
good anamnesis. The dogs were also thoroughly
examined by glass slide impression smears, tape
impression smears, skin scrapings and hair plucks
as per the methods described by Curtis (2001),
Reddy and Sivajothi (2014) in order to confirm py-
oderma and other concurrent dermatoses. Whole
blood and serum were also collected for studying
haematology and serum biochemistry in order to
find out or confirm the associated conditions and
(or) underlying factors. Laboratory procedures
were analysed according the procedures mentioned
in the previous literature (Reddy et al., 2014a;
2014b).
All the dogs were treated orally with en-
rofloxacin at 5 mg/ kg body weight, once daily
(Ihrke, 1996) and the antibiotic was continued up
to one and two weeks beyond the point of clinical
recovery in dogs with recurrent superficial pyo-
derma and recurrent deep pyoderma respectively.
Following therapy, the dogs were monitored clini-
cally at regular intervals i.e. on days 7, 14, 21 and
28 etc. Efficacy of therapy was assessed based on
the attainment of clinical normalcy. By assessing
the clinical symptoms and lesions, response to ther-
apy was graded as excellent, good, fair and poor
(Bloom and Rosser, 2001). Time taken for com-
plete recovery was also noted as per owners’ state-
ment in all the dogs. All the dogs were monitored
for recurrence of pyoderma for a period of six
months after recovery. Supportive therapy was car-
ried out with daily supplementation of a skin tonic
i.e. glossy coat at the dose rates suggested by man-
ufactures and bathing was advised twice weekly
with benzoyl peroxide (2.5%) shampoo. Demodi-
cosis associated with recurrent pyoderma was
treated with oral ivermectin at 300-600 µg/kg body
weight as incremental doses, looking for any toxic
symptoms. Previously, dogs affected with demod-
icosis were also treated with in the similar pattern
(Reddy and Kumari, 2010; Sivajothi et al., 2013a).
Medication was continued till two consequent neg-
ative skin scrapings were obtained at an interval of
ten days. Scabies was treated with oral ivermectin
at 200 µg/kg body weight, weekly twice for one
more week after the skin scrapings becoming neg-
ative besides clinical improvement (Reddy and Ku-
mari, 2013). Ticks and lice were treated with   iver-
mectin at 200 µg/kg body weight, s/c once, fol-
lowed by external application of cypermethrin once
a week to prevent recurrence of external parasitic
infestation. Flea infestation was treated with
fipronil spray twice a month (Medleau et al., 2003).
Hypothyroidism was initiated treatment with oral
Levothyroxin sodium at 20 µg/kg body weight
twice a day. Malassezia dermatitis was treated with
oral ketoconazole at 5 mg/kg body weight per day
and treatment for seborrhea was carried out with
skin tonics containing essential fatty acids. 
Results
Clinical data pertaining to the recurrent pyoderma
dogs was mentioned in Table 1 which includes age,
breed, sex, duration of infection, underlying factors
and previous antibiotic therapy. Observations of
clinical recovery made at weekly intervals is pre-
sented in Table 2. The path of recovery of recurrent
superficial pyderma was shown in Fig. 1.
Discussion
Out of twelve dogs selected for study, seven were
females and five were males. Nine had recurrent
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Fig. 1. Path of recovery of recurrent superficial pyo-
derma with enrofloxacin
superficial pyoderma while three had recurrent
deep pyoderma. Age of dogs ranged from 2 to 8
years, with breeds like Labrador, Pomeranian,
Doberman, Pug and Non-descriptive, weights rang-
ing from 8 to 40 kg. Duration of clinical signs
ranged from 3 to 18 months. The dogs were previ-
ously treated with different antibiotics such as peni-
cillin, lincomycin, enrofloxacin, amoxicillin
clavulanate, cephalexin and amikacin but for a
shorter period of about one week. Thorough anam-
nesis revealed that failure to identify and treat the
underlying factors, use of a narrow spectrum or an
inappropriate antibiotic(s) and therapy of an insuf-
ficient duration might be responsible for recurrent
pyoderma in the dogs presented. But upon thor-
ough investigation it was found that out of 12 dogs
with recurrent pyoderma, demodicosis was noticed
in 2 dogs (16%), followed by Malassezia dermati-
tis, food allergy, keratinization disorders (sebor-
rhea), scabies, tick infestation and flea infestation
in one dog each (8%). Mixed conditions i.e. com-
bination of lice and tick infestation, and a combi-
nation of hypothyroidism and tick infestation in
one dog each (8%) were also noticed. However no
associated conditions could be noticed in the re-
maining 2 dogs (16%). Bloom and Rosser (2001)
failed to identify the underlying cause associated
with pyoderma in 2 dogs out of 21 dogs. Bensignor
and Germain (2004) also could not identify the as-
sociated conditions in two out of 30 dogs of their
study on canine recurrent pyoderma. Reddy et al.
(2014c) also reported the failure to identify the un-
derlying factors in two dogs out of 13 dogs suffer-
ing with recurrent pyoderma in the study.
Out of twelve dogs initiated therapy, ten dogs
could be monitored fully with complete recovery
in all of them indicating that this antibiotic was 100
per cent efficacious. Five cases (cases 3,4,6,7 and
9) of superficial pyoderma improved significantly
by seventh day, as they were free from the primary
lesions such as papules, crusted papules and pus-
tules. However, complete recovery was evident by
fourteenth day with disappearance of even second-
ary lesions like erythema, crusts, hyperpigmenta-
tion, scales etc. Three cases (cases 1, 2 and 5) of
superficial pyoderma exhibited only some response
to therapy by seventh day with resolution of pri-
mary and secondary lesions on 14th and 21st days
of therapy. Variation exhibited in the duration (i.e.
2-3 weeks as per clinical observation or as per
owner statement, days 12-20) of response by the
dogs with recurrent superficial pyoderma might be
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Table 1. Clinical data of 12 dogs with recurrent pyoderma 
due to variation in the extent of lesions, response
of the associated conditions, and the inability to
identify the underlying factor and thus its treat-
ment.
One dog with deep recurrent pyoderma (case 8)
showed only some improvement by the end of 7
days with the presence of deep pustules, folliculitis
and ulcers. Though these lesions healed by two
weeks, secondary lesions such as erythema, hyper-
pigmentation and pruritus were still observed in
this dog. However complete recovery was ob-
served with the use of antibiotics for 21 days. In
another case of recurrent deep pyoderma (case 10),
with generalized demodisosis as an underlying fac-
tor,  resolution of primary and secondary lesions
was observed only on 21 and 28 days of therapy
respectively. Prolonged recovery time in this case
could be due to the severity and extent of the le-
sions and the longer time taken for treating demod-
icosis. In the recent studies on demodicosis was
also mentioned that Demodex was one of the im-
portant associated condition for development of
pyoderma in dogs (Sivajothi et al., 2013b).
These findings are in agreement with Kuhl
(2009) who stated that most superficial pyodermas
require at least three weeks of systemic antibiotics
while the duration of antibiotic therapy for deep py-
odermas is highly variable and they require long
term therapy. All the dogs were monitored for re-
currence for a period of six months. Out of ten dogs
of this group, one dog had recurrence (superficial
pyoderma) after 45 days of therapy. Recurrence
was mainly due to food allergy associated with re-
introduction of chicken and fish. The dog after re-
currence was treated with the same antibiotic,
strictly advising elimination of chicken and fish.
Excellent clinical response with enrofloxacin was
reported by Paradis et al. (2008), and Hillier et al.
(2006) in the treatment of canine pyoderma. No ad-
verse effects were seen with this antibiotic used in
the present study. 
Enrofloxacin is a broad spectrum bactericidal
antibiotic from the class of fluoroquinalones, with
an excellent activity against multi resistant organ-
isms with very rapid killing ability. The drug has
high lipofilicity which allows its penetration into
gram-positive and gram-negative bacteria. The
mode of action is by inhibition of an enzyme called
DNA gyrase, which cuts bacterial DNA, allowing
super coiling of the chromosomes. In mammals the
equivalent enzyme topoisomerase (which is struc-
turally different) is poorly inhibited. The drug has
potent tissue penetration which is partially related
to uptake in to macrophages in chronic inflamma-
tory tissue (Rosenkrantz, 2009).
Conclusion
this study confirmed that enrofloxacin is safe and
effective in the treatment of recurrent superficial
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Table 2.  Therapeutic response with enrofloxacin in  dogs with recurrent pyoderma
Clinical response:
E: Excellent: Complete remission of clinical signs of recurrent pyoderma and point of recovery.
G: Good: Most primary lesions have resolved but mild secondary lesions such as erythema, crusts and scales are still evident.
F: Fair: Some response to treatment but primary and secondary lesions are still evident.
P: Poor: No change or worsening of the condition.
and recurrent deep pyoderma in dogs. The once
daily dosing makes enrofloxacin a very convenient
antibiotic for dog owners, which should increases
owners’ compliance. Addressing the underlying
factors and following proper dose and duration of
the antibiotic might have prevented recurrence of
the disease in the present study.
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